Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1

Jie Hu,Wei-Feng Liu,Xiang-Yu Zhang,Guo-Ming Shi,Xin-Rong Yang,Kai-Qian Zhou,Bo Hu,Fei-Yu Chen,Cheng Zhou,Wan-Yee Lau,Jia Fan,Zheng Wang,Jian Zhou
DOI: https://doi.org/10.1007/s12072-023-10527-8
IF: 9.029
2023-04-29
Hepatology International
Abstract:The dysregulation of exosomal microRNAs plays an important role in the progression of hepatocarcinogenesis. In this study, we investigated the therapeutic potential of synthetic exosomal miR-26a against HCC cells and explored the feasibility of tumor-derived exosomes as drug delivery vehicles.
gastroenterology & hepatology
What problem does this paper attempt to address?